Hippo signaling pathway and mitochondrial dysfunction in Takotsubo syndrome
- 1 April 2023
- journal article
- editorial
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 324 (4) , H525-H527
Abstract
No abstract availableKeywords
Funding Information
- American Heart Association (19TPA34910011)
- HHS | NIH | National Heart, Lung, and Blood Institute (R01HL145459)
This publication has 10 references indexed in Scilit:
- Mitochondrial damage in a Takotsubo syndrome-like mouse model mediated by activation of β-adrenoceptor-Hippo signaling pathwayAmerican Journal of Physiology-Heart and Circulatory Physiology, 2023
- YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overloadJournal of Clinical Investigation, 2022
- Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJAMA Network Open, 2020
- The Role of Estrogen Receptors in Cardiovascular DiseaseInternational Journal of Molecular Sciences, 2020
- Stimulation of β‐adrenoceptors up‐regulates cardiac expression of galectin‐3 and BIM through the Hippo signalling pathwayBritish Journal of Pharmacology, 2019
- Interplay between YAP/TAZ and MetabolismCell Metabolism, 2018
- Pathophysiology of Takotsubo SyndromeCirculation, 2017
- Estrogen regulates Hippo signaling via GPER in breast cancerJournal of Clinical Investigation, 2015
- Mst1 Promotes Cardiac Myocyte Apoptosis through Phosphorylation and Inhibition of Bcl-xLMolecular Cell, 2014
- Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiationGenes & Development, 2013